Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Clinical Benefit of Treatment After Trastuzumab Emtansine for HER2-Positive Metastatic Breast Cancer: A Real-World Multi-Centre Cohort Study in Japan (WJOG12519B)Breast Cancer 2021 Jan 02;[EPub Ahead of Print], T Yokoe, S Kurozumi, K Nozawa, Y Ozaki, T Maeda, S Yazaki, M Onishi, A Fujimoto, S Nakayama, Y Tsuboguchi, T Iwasa, H Sakai, M Ogata, M Terada, M Nishimura, T Onoe, J Masuda, M Kurikawa, H Isaka, K Hagio, A Shimomura, Y Okumura, M Futamura, M Shimokawa, T Takano
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.